An Extension Study of Belcesiran in Patients With Alpha-1 Antitrypsin Deficiency Associated Liver Disease (AATLD)

Exclusion Criteria

• •1. Any condition that, in the opinion of the Investigator, would make the participant unsuitable for enrollment or could interfere with participation in or completion of the study
• •2. Routine use of acetaminophen/paracetamol
• •3. Use of systemically acting steroids in the month prior to Screening and throughout the study period.
• •4. Positive SARS-CoV-2 virus test at Screening
• •5. Any other safety laboratory test result considered clinically significant and unacceptable by the Investigator
• •6. Inability or unwillingness to comply with the specified study procedures, including lifestyle considerations